These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12954590)

  • 21. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells.
    Hughes AK; Stricklett PK; Padilla E; Kohan DE
    Kidney Int; 1996 Jan; 49(1):181-9. PubMed ID: 8770966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endothelin system function in diabetic nephropathy].
    Zanatta CM; Canani LH; Silveiro SP; Burttet L; Nabinger G; Gross JL
    Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):581-8. PubMed ID: 18604370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelins in the normal and diseased kidney.
    Kohan DE
    Am J Kidney Dis; 1997 Jan; 29(1):2-26. PubMed ID: 9002526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases?
    Rodríguez-Pascual F; Busnadiego O; González-Santamaría J
    Life Sci; 2014 Nov; 118(2):156-64. PubMed ID: 24378671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1 and the kidney: new perspectives and recent findings.
    De Miguel C; Speed JS; Kasztan M; Gohar EY; Pollock DM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):35-41. PubMed ID: 26625864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin antagonism and reversal of proteinuric renal disease in humans.
    Barton M
    Contrib Nephrol; 2011; 172():210-222. PubMed ID: 21894001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelins in the kidney: physiology and pathophysiology.
    Kohan DE
    Am J Kidney Dis; 1993 Oct; 22(4):493-510. PubMed ID: 8213787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin antagonists in renal disease.
    Benigni A
    Kidney Int; 2000 Apr; 57(4):1778-94. PubMed ID: 10760116
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytosolic and nuclear signaling by endothelin peptides: mesangial response to glomerular injury.
    Simonson MS; Jones JM; Dunn MJ
    Kidney Int; 1992 Mar; 41(3):542-5. PubMed ID: 1573825
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bioactive lipids in kidney physiology and pathophysiology].
    Sałata D; Dołęgowska B
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():73-83. PubMed ID: 24491898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphological and physiopathological importance of the mesangium in glomerular diseases].
    MONTALDO G; DE MAURIZI M
    Arch Ital Anat Istol Patol; 1951; 24(1):1-38. PubMed ID: 14811687
    [No Abstract]   [Full Text] [Related]  

  • 32. Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese mice.
    Rivera-Gonzalez O; Mills MF; Konadu BD; Wilson NA; Murphy HA; Newberry MK; Hyndman KA; Garrett MR; Webb DJ; Speed JS
    Acta Physiol (Oxf); 2024 Oct; 240(10):e14214. PubMed ID: 39096077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease.
    Kohan DE; Bedard PW; Jenkinson C; Hendry B; Komers R
    Clin Sci (Lond); 2024 Jun; 138(11):645-662. PubMed ID: 38808486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the Endothelin A Receptor in IgA Nephropathy.
    Kohan DE; Barratt J; Heerspink HJL; Campbell KN; Camargo M; Ogbaa I; Haile-Meskale R; Rizk DV; King A
    Kidney Int Rep; 2023 Nov; 8(11):2198-2210. PubMed ID: 38025243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin Receptor Antagonists in Kidney Disease.
    Martínez-Díaz I; Martos N; Llorens-Cebrià C; Álvarez FJ; Bedard PW; Vergara A; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives.
    Lin JR; Wang ZT; Sun JJ; Yang YY; Li XX; Wang XR; Shi Y; Zhu YY; Wang RT; Wang MN; Xie FY; Wei P; Liao ZH
    World J Diabetes; 2022 Apr; 13(4):308-318. PubMed ID: 35582668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating endothelin-1 levels are positively associated with chronic kidney disease in women but not in men: a longitudinal study in the Vara-Skövde cohort.
    Hellgren MI; Jansson PA; Alayar H; Lindblad U; Daka B
    BMC Nephrol; 2021 Oct; 22(1):327. PubMed ID: 34600499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.
    Patel DM; Bose M; Cooper ME
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in redox homeostasis in renal disease.
    Mitchell T; De Miguel C; Gohar EY
    Redox Biol; 2020 Apr; 31():101489. PubMed ID: 32197946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin receptor A and p66Shc regulate spontaneous Ca
    Palygin O; Miller BS; Nishijima Y; Zhang DX; Staruschenko A; Sorokin A
    FASEB J; 2019 Feb; 33(2):2636-2645. PubMed ID: 30303741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.